List of Tables
Table 1. Global Lysosomal Storage Disorder Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Lysosomal Storage Disorder Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Lysosomal Storage Disorder Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Lysosomal Storage Disorder Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Lysosomal Storage Disorder Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Lysosomal Storage Disorder Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Lysosomal Storage Disorder Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Lysosomal Storage Disorder Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Lysosomal Storage Disorder Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Lysosomal Storage Disorder Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Lysosomal Storage Disorder Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Lysosomal Storage Disorder Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lysosomal Storage Disorder Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Lysosomal Storage Disorder Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lysosomal Storage Disorder Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Lysosomal Storage Disorder Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Lysosomal Storage Disorder Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Lysosomal Storage Disorder Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Lysosomal Storage Disorder Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Lysosomal Storage Disorder Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Lysosomal Storage Disorder Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Lysosomal Storage Disorder Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Lysosomal Storage Disorder Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Lysosomal Storage Disorder Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Lysosomal Storage Disorder Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Lysosomal Storage Disorder Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Lysosomal Storage Disorder Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Lysosomal Storage Disorder Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Lysosomal Storage Disorder Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Lysosomal Storage Disorder Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Lysosomal Storage Disorder Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Lysosomal Storage Disorder Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Lysosomal Storage Disorder Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Lysosomal Storage Disorder Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Lysosomal Storage Disorder Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Lysosomal Storage Disorder Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Lysosomal Storage Disorder Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Lysosomal Storage Disorder Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Lysosomal Storage Disorder Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Lysosomal Storage Disorder Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Lysosomal Storage Disorder Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Lysosomal Storage Disorder Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Lysosomal Storage Disorder Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Lysosomal Storage Disorder Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Lysosomal Storage Disorder Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Lysosomal Storage Disorder Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Lysosomal Storage Disorder Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Lysosomal Storage Disorder Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Lysosomal Storage Disorder Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Lysosomal Storage Disorder Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Lysosomal Storage Disorder Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Lysosomal Storage Disorder Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Lysosomal Storage Disorder Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Lysosomal Storage Disorder Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Lysosomal Storage Disorder Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Lysosomal Storage Disorder Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Lysosomal Storage Disorder Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Lysosomal Storage Disorder Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Lysosomal Storage Disorder Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Lysosomal Storage Disorder Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Lysosomal Storage Disorder Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Lysosomal Storage Disorder Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Lysosomal Storage Disorder Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Lysosomal Storage Disorder Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Lysosomal Storage Disorder Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Lysosomal Storage Disorder Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Lysosomal Storage Disorder Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Lysosomal Storage Disorder Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novartis Lysosomal Storage Disorder Drugs Product
Table 74. Novartis Recent Developments/Updates
Table 75. Johnson & Johnson Company Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Johnson & Johnson Lysosomal Storage Disorder Drugs Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Teva Pharmaceutical Company Information
Table 81. Teva Pharmaceutical Description and Business Overview
Table 82. Teva Pharmaceutical Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Teva Pharmaceutical Lysosomal Storage Disorder Drugs Product
Table 84. Teva Pharmaceutical Recent Developments/Updates
Table 85. Merck & Co Company Information
Table 86. Merck & Co Description and Business Overview
Table 87. Merck & Co Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Merck & Co Lysosomal Storage Disorder Drugs Product
Table 89. Merck & Co Recent Developments/Updates
Table 90. AbbVie Company Information
Table 91. AbbVie Description and Business Overview
Table 92. AbbVie Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. AbbVie Lysosomal Storage Disorder Drugs Product
Table 94. AbbVie Recent Developments/Updates
Table 95. Pfizer Company Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Pfizer Lysosomal Storage Disorder Drugs Product
Table 99. Pfizer Recent Developments/Updates
Table 100. GlaxoSmithKline Company Information
Table 101. GlaxoSmithKline Description and Business Overview
Table 102. GlaxoSmithKline Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. GlaxoSmithKline Lysosomal Storage Disorder Drugs Product
Table 104. GlaxoSmithKline Recent Developments/Updates
Table 105. Sanofi Company Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Sanofi Lysosomal Storage Disorder Drugs Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Merck KGaA Company Information
Table 111. Merck KGaA Description and Business Overview
Table 112. Merck KGaA Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Merck KGaA Lysosomal Storage Disorder Drugs Product
Table 114. Merck KGaA Recent Developments/Updates
Table 115. Abbott Company Information
Table 116. Abbott Description and Business Overview
Table 117. Abbott Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Abbott Lysosomal Storage Disorder Drugs Product
Table 119. Abbott Recent Developments/Updates
Table 120. Boehringer Ingelheim International Company Information
Table 121. Boehringer Ingelheim International Description and Business Overview
Table 122. Boehringer Ingelheim International Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Boehringer Ingelheim International Lysosomal Storage Disorder Drugs Product
Table 124. Boehringer Ingelheim International Recent Developments/Updates
Table 125. Takeda Pharmaceutical Company Information
Table 126. Takeda Pharmaceutical Description and Business Overview
Table 127. Takeda Pharmaceutical Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Takeda Pharmaceutical Lysosomal Storage Disorder Drugs Product
Table 129. Takeda Pharmaceutical Recent Developments/Updates
Table 130. Amicus Therapeutics Company Information
Table 131. Amicus Therapeutics Description and Business Overview
Table 132. Amicus Therapeutics Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Amicus Therapeutics Lysosomal Storage Disorder Drugs Product
Table 134. Amicus Therapeutics Recent Developments/Updates
Table 135. Moderna Company Information
Table 136. Moderna Description and Business Overview
Table 137. Moderna Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Moderna Lysosomal Storage Disorder Drugs Product
Table 139. Moderna Recent Developments/Updates
Table 140. Biomarin Company Information
Table 141. Biomarin Description and Business Overview
Table 142. Biomarin Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Biomarin Lysosomal Storage Disorder Drugs Product
Table 144. Biomarin Recent Developments/Updates
Table 145. JCR Pharmaceutical Company Information
Table 146. JCR Pharmaceutical Description and Business Overview
Table 147. JCR Pharmaceutical Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. JCR Pharmaceutical Lysosomal Storage Disorder Drugs Product
Table 149. JCR Pharmaceutical Recent Developments/Updates
Table 150. ISU ABXIS Company Information
Table 151. ISU ABXIS Description and Business Overview
Table 152. ISU ABXIS Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. ISU ABXIS Lysosomal Storage Disorder Drugs Product
Table 154. ISU ABXIS Recent Developments/Updates
Table 155. Idorsia Pharmaceuticals Company Information
Table 156. Idorsia Pharmaceuticals Description and Business Overview
Table 157. Idorsia Pharmaceuticals Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Idorsia Pharmaceuticals Lysosomal Storage Disorder Drugs Product
Table 159. Idorsia Pharmaceuticals Recent Developments/Updates
Table 160. AVROBIO Company Information
Table 161. AVROBIO Description and Business Overview
Table 162. AVROBIO Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. AVROBIO Lysosomal Storage Disorder Drugs Product
Table 164. AVROBIO Recent Developments/Updates
Table 165. Resverlogix Company Information
Table 166. Resverlogix Description and Business Overview
Table 167. Resverlogix Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Resverlogix Lysosomal Storage Disorder Drugs Product
Table 169. Resverlogix Recent Developments/Updates
Table 170. Chiesi Farmaceutici Company Information
Table 171. Chiesi Farmaceutici Description and Business Overview
Table 172. Chiesi Farmaceutici Lysosomal Storage Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. Chiesi Farmaceutici Lysosomal Storage Disorder Drugs Product
Table 174. Chiesi Farmaceutici Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Lysosomal Storage Disorder Drugs Distributors List
Table 178. Lysosomal Storage Disorder Drugs Customers List
Table 179. Lysosomal Storage Disorder Drugs Market Trends
Table 180. Lysosomal Storage Disorder Drugs Market Drivers
Table 181. Lysosomal Storage Disorder Drugs Market Challenges
Table 182. Lysosomal Storage Disorder Drugs Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Lysosomal Storage Disorder Drugs
Figure 2. Global Lysosomal Storage Disorder Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Lysosomal Storage Disorder Drugs Market Share by Type: 2025 & 2032
Figure 4. Enzyme Replacement Therapy Product Picture
Figure 5. Stem Cell Therapy Product Picture
Figure 6. Substrate Reduction Therapy Product Picture
Figure 7. Other Product Picture
Figure 8. Global Lysosomal Storage Disorder Drugs Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Lysosomal Storage Disorder Drugs Market Share by Application: 2025 & 2032
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Lysosomal Storage Disorder Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Lysosomal Storage Disorder Drugs Market Size (US$ Million), 2021–2032
Figure 15. Global Lysosomal Storage Disorder Drugs Sales (K Units), 2021–2032
Figure 16. Global Lysosomal Storage Disorder Drugs Average Price (US$/Unit), 2021–2032
Figure 17. Lysosomal Storage Disorder Drugs Report Years Considered
Figure 18. Lysosomal Storage Disorder Drugs Sales Share by Manufacturers in 2025
Figure 19. Global Lysosomal Storage Disorder Drugs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Lysosomal Storage Disorder Drugs Players: Market Share by Revenue in Lysosomal Storage Disorder Drugs in 2025
Figure 21. Lysosomal Storage Disorder Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Lysosomal Storage Disorder Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Lysosomal Storage Disorder Drugs Sales Market Share by Country (2021–2032)
Figure 24. North America Lysosomal Storage Disorder Drugs Revenue Market Share by Country (2021–2032)
Figure 25. United States Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Lysosomal Storage Disorder Drugs Sales Market Share by Country (2021–2032)
Figure 28. Europe Lysosomal Storage Disorder Drugs Revenue Market Share by Country (2021–2032)
Figure 29. Germany Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Lysosomal Storage Disorder Drugs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Lysosomal Storage Disorder Drugs Revenue Market Share by Region (2021–2032)
Figure 36. China Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Lysosomal Storage Disorder Drugs Sales Market Share by Country (2021–2032)
Figure 44. Latin America Lysosomal Storage Disorder Drugs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Lysosomal Storage Disorder Drugs Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Lysosomal Storage Disorder Drugs Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Lysosomal Storage Disorder Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Lysosomal Storage Disorder Drugs by Type (2021–2032)
Figure 55. Global Revenue Market Share of Lysosomal Storage Disorder Drugs by Type (2021–2032)
Figure 56. Global Lysosomal Storage Disorder Drugs Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Lysosomal Storage Disorder Drugs by Application (2021–2032)
Figure 58. Global Revenue Market Share of Lysosomal Storage Disorder Drugs by Application (2021–2032)
Figure 59. Global Lysosomal Storage Disorder Drugs Price (US$/Unit) by Application (2021–2032)
Figure 60. Lysosomal Storage Disorder Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
